Loading clinical trials...
Loading clinical trials...
Pilot Study: Tailored Anticoagulation for Noncontinuous AF
Conditions
Interventions
Drug (Direct thrombin or Factor Xa inhibitor)
Locations
10
United States
Jeffrey Goodman, MD
Los Angeles, California, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Sparrow Research Institute
Lansing, Michigan, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Start Date
January 1, 2013
Primary Completion Date
December 1, 2016
Completion Date
August 1, 2017
Last Updated
August 13, 2020
NCT05147792
NCT06935591
NCT05963698
NCT04947657
NCT03546374
NCT06686485
Lead Sponsor
Abbott Medical Devices
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions